Valganciclovir
Back to searchMolecule Structure
Scientific Name
Valganciclovir
Description of the Drug
Valganciclovir is an antiviral medication used to treat cytomegalovirus (CMV) retinitis in patients diagnosed with acquired immunodeficiency syndrome (AIDS).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01610
http://www.drugbank.ca/drugs/DB01610
Brand Name(s)
Not Available
Company Owner(s)
Cipla Ltd, Msn Laboratories Private Ltd, Ajanta Pharma Ltd, Hoffmann La Roche Inc, Actavis Laboratories Fl Inc, Mylan Pharmaceuticals Inc A Viatris Co, Aurobindo Pharma Ltd, Dr Reddys Laboratories Ltd, Hetero Labs Ltd Unit V, Granules Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human herpesvirus 1 DNA polymerase | SINGLE PROTEIN | INHIBITOR | CHEMBL1872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL28996 | SCHEMBL22357189 | |||
| PharmGKB | PA10227 | ||||
| Human Metabolome Database | HMDB0015548 | ||||
| DrugBank | DB01610 | ||||
| PubChem: Thomson Pharma | 16292870 | 14852135 | 14852136 | 16867892 | 15916891 |
| PubChem | 135413535 | ||||
| Nikkaji | J1.170.632K | ||||
| EPA CompTox Dashboard | DTXSID8048288 | ||||
| DrugCentral | 2801 | ||||
| Brenda | 208587 | 208586 | 72233 | ||
| Guide to Pharmacology | 4716 | ||||
| rxnorm | VALGANCICLOVIR | VALCYTE | VALGANCICLOVIR HYDROCHLORIDE | ||
| ChEBI | 63635 |
